City Fertility Revenue and Competitors

Kelvin Grove, Australia

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • City Fertility's estimated annual revenue is currently $49.9M per year.(i)
  • City Fertility's estimated revenue per employee is $297,000

Employee Data

  • City Fertility has 168 Employees.(i)
  • City Fertility grew their employee count by 17% last year.

City Fertility's People

NameTitleEmail/Phone
1
VP FinanceReveal Email/Phone
2
Compliance OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Scientific DirectorReveal Email/Phone
5
Lead Embryologist & Special Projects OfficerReveal Email/Phone
6
Medical Director NSWReveal Email/Phone
7
Chief Operations OfficerReveal Email/Phone
8
CEO, Scientific Director & FounderReveal Email/Phone
9
Director NursingReveal Email/Phone
10
Director NursingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.6M42-11%$15MN/A
Add Company

What Is City Fertility?

Established in 2003, City Fertility is one of Australia 's leading IVF & fertility service groups with 9 clinics, 65 consulting rooms and over 40 doctors nationwide. We provide seamless care across the full fertility spectrum, while ensuring the best possible chances of conception for our patients through our rigorous protocols and actively taking part in research projects and science-based treatments. City Fertility has recently joined the CHA IVF global network, which has a 35-year track record as world-renowned pioneers in reproductive medicine. CHA has achieved an exceptional international reputation for its cutting-edge academic research and technologies in reproductive medicine and IVF, with unique expertise in treating complex cases, establishing new standards for global best practices in fertility-related treatments and achieving scientific breakthroughs that have become widely accepted clinical standards today. Amongst other accomplishments, CHA pioneered the world's first successful pregnancy and birth through in vitro maturation of human immature oocytes (IVM) in 1988 and the world's first successful birth with frozen oocytes using EM grids in 1999. It is also a leading research contributor to global scientific bodies including ASRM, ESHRE and PSRM, continues to explore new scientific areas at its research institutes and clinical centres worldwide. The Partnership is part of City Fertility's desire to further optimise best practice in patient care. Together with CHA and SMG, we will continue to grow in Australia with a strong focus on excellence in reproductive medicine and research. This Partnership would provide City Fertility with unique access to CHA and SMG's globally renowned medical, operational, and research & development expertise. We expect that the Partnership will further expand City Fertility's capabilities and enhance our continued focus on delivering clinical excellence and world-class results for our patients with a specific emphasis on achieving the best pregnancy rates in Australia.

keywords:N/A

N/A

Total Funding

168

Number of Employees

$49.9M

Revenue (est)

17%

Employee Growth %

N/A

Valuation

N/A

Accelerator

City Fertility News

2022-04-20 - Flu virus killed wild horses at Bureau of Land Management ...

... such as fertility control vaccines, to prevent "more horses from entering ... The horses at Cañon City began showing respiratory and...

2022-04-13 - Et Tu, New York? Couple Files LGBTQ+ IVF Discrimination ...

Despite the law explicating prohibiting discrimination on the basis of sexual orientation, New York City denies fertility coverage to gay...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$203.2M6020%N/A